Mohamed Elbasiony
Overview
Explore the profile of Mohamed Elbasiony including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
El-Eshmawy M, Barakat A, El-Baiomy A, El-Naga M, Elbasiony M
Nutr Metab (Lond)
. 2025 Mar;
22(1):19.
PMID: 40069760
Background: A bidirectional relationship between hypothyroidism and nonalcoholic fatty liver disease (NAFLD) has been proposed. Fasting hyperglucagonemia in patients with hypothyroidism induced NAFLD needs to be further clarified. The aim...
2.
Choudhury A, Kulkarni A, Arora V, Soin A, Dokmeci A, Chowdhury A, et al.
Hepatol Int
. 2025 Feb;
19(1):1-69.
PMID: 39961976
Acute-on-chronic liver failure (ACLF) is a condition associated with high mortality in the absence of liver transplantation. There have been various definitions proposed worldwide. The first consensus report of the...
3.
Kumar A, Arora A, Choudhury A, Arora V, Rela M, Jothimani D, et al.
Am J Gastroenterol
. 2024 Jul;
PMID: 39016385
Introduction: The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) and its complication, MAFLD-related acute-on-chronic liver failure (MAFLD-ACLF), is rising. Yet, factors determining patient outcomes in MAFLD-ACLF remain understudied. Methods:...
4.
Elbasiony M, Abed H, Alaskalany H, Saleh A
Med J Armed Forces India
. 2023 Nov;
79(6):710-717.
PMID: 37981928
Background: Early detection of esophageal varices (EV) before the first attack of bleeding is crucial for primary prophylaxis. The current work aims to investigate the use of a combination of...
5.
Said E, Abdel-Gawad M, Abdelsameea E, Elshemy E, Abdeen N, Elbasiony M, et al.
Eur J Gastroenterol Hepatol
. 2023 Aug;
35(10):1204-1210.
PMID: 37577784
Objectives: The objective of this study was to screen for significant hepatic fibrosis or steatosis in asymptomatic, apparently healthy subjects by using Vibration-controlled transient elastography and controlled attenuation parameter (CAP)....
6.
Tag-Adeen M, Malak M, Abdel-Gawad M, Abu-Elfatth A, Eldamarawy R, Alzamzamy A, et al.
Front Med (Lausanne)
. 2023 Jan;
9:1018201.
PMID: 36714140
Background And Aim: Indeterminate biliary stricture (IBS) is a frequently encountered clinical problem. In this study, we aimed to highlight the clinical characteristics, risk factors and diagnostic outcomes of patients...
7.
Hussein O, El-Ghitany E, Omran M, Matariek G, Elbadaly E, Hamdy R, et al.
Breast Cancer (Auckl)
. 2021 Apr;
15:11782234211002499.
PMID: 33814915
Background: Hepatitis C virus (HCV) is a known risk factor for hepatocellular carcinoma. Several epidemiological studies have pointed out to an association of HCV infection with other extrahepatic malignancies. The...
8.
Shiha G, Soliman R, Elbasiony M, Darwish N, Mousa S
Sci Rep
. 2021 Feb;
11(1):4623.
PMID: 33633233
The new anti-hepatitis C virus (HCV) molecules improve treatment regimens and outcomes, but there are drawbacks. New combinations should target the HCV infectious cycle and be effective against all HCV...
9.
Shiha G, Waked I, Soliman R, Elbasiony M, Gomaa A, Mikhail N, et al.
Liver Int
. 2020 Sep;
40(11):2828-2833.
PMID: 32946647
Background & Aims: Hepatocellular carcinoma (HCC) risk persists after hepatitis C virus (HCV) eradication with direct-acting antivirals (DAAs), particularly in patients with cirrhosis. Identifying those who are likely to develop...
10.
Shiha G, Soliman R, Elbasiony M, Darwish N, Mousa S
Sci Rep
. 2019 Sep;
9(1):13593.
PMID: 31537880
Emergence of new molecules acting directly on the hepatitic C virus (HCV) has improved treatment outcomes. However, there is a risk of selecting viral escape mutants, so a new combination...